Assunta Viola - Concepedia

Author

Assunta Viola

Fatebenefratelli Hospital

Also Known As

Assunta Viola, Viola, Assunta

Publications

349

Citations

H-Index

Concepts

All Affiliations

Fatebenefratelli Hospital Ospedale Antonio Cardarelli Federico II University Hospital University of Florence

About

Assunta Viola is an author at Fatebenefratelli Hospital specializing in medicine, hematology, and cell transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	168
2	Health Sciences	5	5	97
3	Cellular Therapies	4	4	79
4	Blood Transplantation	2	2	56
5	Genetic Medicine	1	1	22

Assunta Viola

Publications

296

Citations

H-Index

Page 1

	Year	Citations
Outpatient-based peripheral blood stem cell transplantation for patients with multiple myeloma Felicetto Ferrara, Salvatore Palmieri, Assunta Viola, The Hematology Journal Hematological MalignancyCell TherapyTransplantationMarrow TransplantationStem Cell Transplantation	2004	38
<i>De novo</i> acute myeloid leukemia with multilineage dysplasia: treatment results and prognostic evaluation from a series of 44 patients treated with fludarabine, cytarabine and G‐CSF (FLAG) Felicetto Ferrara, Salvatore Palmieri, Barbara Pocali, European Journal Of Haematology	2002	37
Comparison of fixed dose pegfilgrastim and daily filgrastim after autologous stem cell transplantation in patients with multiple myeloma autografted on a outpatient basis Felicetto Ferrara, T. Izzo, Clelia Criscuolo, Hematological Oncology	2010	24
High‐dose idarubicin and busulphan as conditioning to autologous stem cell transplantation in adult patients with acute myeloid leukaemia Felicetto Ferrara, Salvatore Palmieri, Mariacarla De Simone, British Journal of Haematology	2004	22
HFE gene mutations in patients with acute leukemia Assunta Viola, Leonilde Pagano, Daniela Laudati, Leukemia & lymphoma/Leukemia and lymphoma Hematological MalignancyMedicineGeneticsAcute Myeloid LeukemiaHematology	2006	22
Interferon Beta-1a treatment promotes SARS-CoV-2 mRNA vaccine response in multiple sclerosis subjects Giorgia Teresa Maniscalco, Valentino Manzo, Anne Lise Ferrara, Multiple Sclerosis and Related Disorders VaccinationVaccine DevelopmentMedicineImmunologyMultiple Sclerosis Subjects	2021	20
Complete remission in acute myeloid leukaemia with t(8;21) following treatment with G‐CSF: flow cytometric analysis of <i>in vivo</i> and <i>in vitro</i> effects on cell maturation Felicetto Ferrara, Rosa Di Noto, Assunta Viola, British Journal of Haematology	1999	19
Ifosfamide, Epirubicin and Etoposide (IEV) Regimen as Salvage and Mobilization Therapy for Refractory or Early Relapsing Patients with Aggressive Non-Hodgkin's Lymphoma Barbara Pocali, Mariacarla De Simone, Mario Annunziata, Leukemia & lymphoma/Leukemia and lymphoma Cell TherapySurgical OncologyImmunologyPathologyImmunotherapy	2004	18
Myeloablative chemotherapy followed by autologous stem cell infusion may overcome the adverse prognostic impact of FLT3 (foetal liver tyrosine kinase 3) mutations in patients with acute myeloid leukaemia and normal karyotype Salvatore Palmieri, Felicetto Ferrara, Franco Leoni, Hematological Oncology Mixed-phenotype Acute LeukemiaPathologyMyeloid NeoplasiaHematological MalignancyBone Marrow Failure	2006	18
High-dose cytarabine as consolidation treatment for patients with acute myeloid leukemia with t(8;21) Salvatore Palmieri, Lucia Sebastio, Giuseppina Mele, Leukemia Research Hematological MalignancyOncologyAcute Myeloid LeukemiaHematologyPharmacology	2002	18

Page 1